HHS has asked the FDA to revise testosterone prescribing information, removing an age‑related limit and updating prostate and blood‑pressure warnings.

A New England Journal of Medicine paper proposing organ removal linked to euthanasia has reignited a fierce ethics debate over consent and public trust.

A JAMA Network Open analysis shows many U.S. eighth‑graders underestimate the danger of fentanyl; local data show adolescent fentanyl deaths have surged.

Federal safety officials say about 1.72 million Cuisinart grill brushes may shed metal bristles, posing an ingestion risk; Conair will offer refunds.

A new review maps lymphatic networks along the spine and connects spinal tissues to brain clearance and inflammation. Simple five‑minute moves may help support flow.

A Silver Spring pest-control company says it has begun releasing roughly 600,000 Wolbachia-infected male 'ZAP' mosquitoes across the DMV this summer to curb Asian tiger mosquitoes. Officials say males don't bite and the program is regulated by EPA rules.

Amgen is voluntarily recalling hundreds of thousands of Corlanor and Sensipar bottles after unexpected foreign material was found on tablet surfaces. Regulators say patient risk is low but recommend checking labels and consulting your pharmacist.

A Portland seven‑time skin‑cancer survivor helped push a law that paves a path for Medicare to cover multi‑cancer blood tests — implementation depends on FDA and CMS reviews.

The FDA told Amazon it sold three unapproved topical products marketed for penile conditions and gave the company 15 business days to respond.

A National Academies review found ABA meets the evidence bar, but TRICARE’s demonstration rules and paperwork are keeping many military families from hands‑on care.

A watchdog says crisis pregnancy centers are advertising they can "rule out" ectopic pregnancy after a single scan. Medical groups say diagnosis usually requires follow‑up testing.

A UNSW‑led review published in Carcinogenesis finds e‑cigarettes "likely" carcinogenic; U.S. health agencies and experts are weighing the evidence.

A Pittsburgh verdict has thrust the unregulated delta‑8 THC market into the spotlight as health officials warn of contaminants and adverse reactions.